Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis

Experimental Cell Research

Volumn 302, Issue 1, 2005, Pages 69-82

  McNeish, I A ^a,c   Lopes, R ^a   Bell, S J ^a   McKay, T R ^a   Fernandez, M ^a   Lockley, M ^a   Wheatley, S P ^b   Lemoine, N R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Ovarian carcinoma cells; Smac; Survivin

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE; CYCLOHEXIMIDE; PROTEASOME; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION; UBIQUITINATION; XENOGRAFT;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS;

EID: 8444237426     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.08.029     Document Type: Article

References (69)

1. J.C. Reed Dysregulation of apoptosis in cancer J. Clin. Oncol. 17 1999 2941 2953
2. B.B. Wolf, M. Schuler, W. Li, B. Eggers-Sedlet, W. Lee, P. Tailor, P. Fitzgerald, G.B. Mills, and D.R. Green Defective Cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity J. Biol. Chem. 276 2001 34244 34251
3. E. Asselin, G.B. Mills, and B.K. Tsang XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells Cancer Res. 61 2001 1862 1868
4. J.R. Liu, A.W. Opipari, L. Tan, Y. Jiang, Y. Zhang, H. Tang, and G. Nunez Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance Cancer Res. 62 2002 924 931
5. N. Zaffaroni, M. Pennati, G. Colella, P. Perego, R. Supino, L. Gatti, S. Pilotti, F. Zunino, and M.G. Daidone Expression of the anti-apoptotic gene survivin correlates with Taxol resistance in human ovarian cancer Cell. Mol. Life Sci. 59 2002 1406 1412
6. A. Eliopoulos, D. Kerr, J. Herod, E. Hodgkins, S. Krajewski, J. Reed, and L. Young The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2 Oncogene 11 1995 1217 1228
7. S.J. Riedl, M. Renatus, R. Schwarzenbacher, Q. Zhou, C. Sun, S.W. Fesik, R.C. Liddington, and G.S. Salvesen Structural basis for the inhibition of caspase-3 by XIAP Cell 104 2001 791 800
8. E.N. Shiozaki, J. Chai, D.J. Rigotti, S.J. Riedl, P.W. Li, S.M. Srinivasula, E.S. Alnemri, R. Fairman, and Y. Shi Mechanism of XIAP-mediated inhibition of caspase-9 Mol. Cell 11 2003 519 527
9. Y. Yang, S. Fang, J.P. Jensen, A.M. Weissman, and J.D. Ashwell Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli Science 288 2000 874 877
10. A. Verhagen, P. Ekert, M. Pakusch, J. Silke, L. Connolly, G. Reid, R. Moritz, R. Simpson, and D. Vaux Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins Cell 102 2000 43 53
11. C. Du, M. Fang, Y. Li, L. Li, and X. Wang Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
12. Y. Deng, Y. Lin, and X. Wu TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO Genes Dev. 16 2002 33 45
13. D. Chauhan, T. Hideshima, S. Rosen, J.C. Reed, S. Kharbanda, and K.C. Anderson Apaf-1/Cytochrome c-independent and Smac-dependent induction of apoptosis in Multiple Myeloma (MM) cells J. Biol. Chem. 276 2001 24453 24456
14. H. Okada, W.-K. Suh, J. Jin, M. Woo, C. Du, A. Elia, G.S. Duncan, A. Wakeham, A. Itie, S.W. Lowe, X. Wang, and T.W. Mak Generation and characterization of Smac/DIABLO-deficient mice Mol. Cell. Biol. 22 2002 3509 3517
15. R. Hegde, S.M. Srinivasula, Z. Zhang, R. Wassell, R. Mukattash, L. Cilenti, G. DuBois, Y. Lazebnik, A.S. Zervos, T. Fernandes-Alnemri, and E.S. Alnemri Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction J. Biol. Chem. 277 2002 432 438
16. L.M. Martins, I. Iaccarino, T. Tenev, S. Gschmeissner, N.F. Totty, N.R. Lemoine, J. Savopoulos, C.W. Gray, C.L. Creasy, C. Dingwall, and J. Downward The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif J. Biol. Chem. 277 2002 439 444
17. R. Hegde, S.M. Srinivasula, P. Datta, M. Madesh, R. Wassell, Z. Zhang, N. Cheong, J. Nejmeh, T. Fernandes-Alnemri, S.-I. Hoshino, and E.S. Alnemri The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein J. Biol. Chem. 278 2003 38699 38706
18. K. Hell, M. Saleh, G.D. Crescenzo, M.D. O'Connor-McCourt, and D.W. Nicholson Substrate cleavage by caspases generates protein fragments with Smac/DIABLO-like activities Cell Death Differ. 10 2003 1234 1239
19. F. Guo, R. Nimmanapalli, S. Paranawithana, S. Wittman, D. Griffin, P. Bali, E. O'Bryan, C. Fumero, H.G. Wang, and K. Bhalla Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis Blood 99 2002 3419 3426
20. S. Fulda, W. Wick, M. Weller, and K.M. Debatin Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo Nat. Med. 8 2002 808 815
21. C.R. Arnt, M.V. Chiorean, M.P. Heldebrant, G.J. Gores, and S.H. Kaufmann Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAPI in situ J. Biol. Chem. 277 2002 44236 44243
22. J.H. Silke, T. Kratina, P.G. Ekert, M. Pakusch, and D.L. Vaux Unlike DIABLO/Smac, grim promotes global ubiquitination and specific degradation of XIAP and neither cause apoptosis J. Biol. Chem. 279 2004
23. G. Ambrosini, C. Adida, and D. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat. Med. 3 1997 917 921
24. S. Shin, B.J. Sung, Y.S. Cho, H.J. Kim, N.C. Ha, J.I. Hwang, C.W. Chung, Y.K. Jung, and B.H. Oh An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7 Biochemistry 40 2001 1117 1123
25. D. Grossman, P.J. Kim, J.S. Schechner, and D.C. Altieri Inhibition of melanoma tumor growth in vivo by survivin targeting Proc. Natl. Acad. Sci. U. S. A. 98 2001 635 640
26. R.A. Olie, A.P. Simoes-Wust, B. Baumann, S.H. Leech, D. Fabbro, R.A. Stahel, and U. Zangemeister-Wittke A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy Cancer Res. 60 2000 2805 2809
27. M. Pennati, M. Binda, G. Colella, M. Zoppe, M. Folini, S. Vignati, A. Valentini, L. Citti, M. De Cesare, G. Pratesi, M. Giacca, M.G. Daidone, and N. Zaffaroni Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells Oncogene 23 2004 386 394
28. A. Temme, M. Rieger, F. Reber, D. Lindemann, B. Weigle, P. Diestelkoetter-Bachert, G. Ehninger, M. Tatsuka, Y. Terada, and E.P. Rieber Localization, dynamics and function of survivin revealed by expression of functional SurvivinDsRed fusion proteins in the living cell Mol. Biol. Cell 14 2003 78 92
29. D.A. Skoufias, C. Mollinari, F.B. Lacroix, and R.L. Margolis Human survivin is a kinetochore-associated passenger protein J. Cell Biol. 151 2000 1575 1582
30. S.M.A. Lens, R.M.F. Wolthuis, R. Klompmaker, J. Kauw, R. Agami, T. Brummelkamp, G. Kops, and R.H. Medema Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension EMBO J. 22 2003 2934 2947
31. S.P. Wheatley, A. Carvalho, P. Vagnarelli, and W.C. Earnshaw INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis Curr. Biol. 11 2001 886 890
32. M.A. Bolton, W.J. Lan, S.E. Powers, M.L. McCleland, J. Kuang, and P.T. Stukenberg Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and in a complex inase activity is phosphorylation Mol. Biol. Cell 13 2002 3064 3077
33. J. Chen, S. Jin, S.K. Tahir, H. Zhang, X. Liu, A.V. Sarthy, T.P. McGonigal, Z. Liu, S.H. Rosenberg, and S.-C. Ng Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells J. Biol. Chem. 278 2003 486 490
34. H. Marusawa, S.-I. Matsuzawa, K. Welsh, H. Zou, R. Armstrong, I. Tamm, and J.C. Reed HBXIP functions as a cofactor of survivin in apoptosis suppression EMBO J. 22 2003 2729 2740
35. T. Liu, B. Brouha, and D. Grossman Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells Oncogene 23 2004 39 48
36. E. Beltrami, J. Plescia, J.C. Wilkinson, C.S. Duckett, and D.C. Altieri Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis J. Biol. Chem. 279 2004 2077 2084
37. I.A. McNeish, S. Bell, T. McKay, T. Tenev, M. Marani, and N.R. Lemoine Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway Exp. Cell Res. 286 2003 186 198
38. G. Rigaut, A. Shevchenko, B. Rutz, M. Wilm, M. Mann, and B. Seraphin A generic protein purification method for protein complex characterization and proteome exploration Nat. Biotechnol. 17 1999 1030 1032
39. J. Zhao, T. Tenev, L. Martins, J. Downward, and N. Lemoine The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner J. Cell Sci. 113 2000 4363 4371
40. L. Yang, Z. Cao, H. Yan, and W.C. Wood Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy Cancer Res. 63 2003 6815 6824
41. A. Livne, R. Shtrichman, and T. Kleinberger Caspase activation by adenovirus E4orf4 protein is cell line specific and is mediated by the death receptor pathway J. Virol. 75 2001 789 798
42. D.L. Roberts, W. Merrison, M. MacFarlane, and G.M. Cohen The inhibitor of apoptosis protein-binding domain of Smac is not essential for its proapoptotic activity J. Cell Biol. 153 2001 221 228
43. Z.H. Liu, C.H. Sun, E.T. Olejniczak, R.P. Meadows, S.F. Betz, T. Oost, J. Herrmann, J.C. Wu, and S.W. Fesik Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain Nature 408 2000 1004 1008
44. S.M. Srinivasula, R. Hegde, A. Saleh, P. Datta, E. Shiozaki, J. Chai, R.A. Lee, P.D. Robbins, T. Fernandes-Alnemri, Y. Shi, and E.S. Alnemri A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis Nature 410 2001 112 116
45. D. Acehan, X.J. Jiang, D.G. Morgan, J.E. Heuser, X.D. Wang, and C.W. Akey Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation Mol. Cell 9 2002 423 432
46. M. Renatus, H.R. Stennicke, F.L. Scott, R.C. Liddington, and G.S. Salvesen Dimer formation drives the activation of the cell death protease caspase 9 Proc. Natl. Acad. Sci. U. S. A. 98 2001 14250 14255
47. P. Ekert, J. Silke, C. Hawkins, A. Verhagen, and D. Vaux DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9 J. Cell Biol. 152 2001 483 490
48. D. Vucic, K. Deshayes, H. Ackerly, M.T. Pisabarro, S. Kadkhodayan, W.J. Fairbrother, and V.M. Dixit SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) J. Biol. Chem. 277 2002 12275 12279
49. M. Verdecia, H.-K. Huang, E. Dutil, D. Kaiser, T. Hunter, and J. Noel Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement Nat. Struct. Biol. 7 2000 602 608
50. L.E. Luque, K.P. Grape, and M. Junker A highly conserved arginine is critical for the functional folding of inhibitor of apoptosis (IAP) BIR domains Biochemistry 41 2002 13663 13671
51. Z. Song, X. Yao, and M. Wu Direct interaction between Survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during Taxol-induced apoptosis J. Biol. Chem. 278 2003 23130 23140
52. S.W. Muchmore, J. Chen, C. Jakob, D. Zakula, E.D. Matayoshi, W. Wu, H.C. Zhang, F.Z. Li, S.C. Ng, and D.C. Altieri Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin Mol. Cell 6 2000 173 182
53. L. Chantalat, D.A. Skoufias, J.P. Kleman, B. Jung, O. Dideberg, and R.L. Margolis Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions Mol. Cell 6 2000 183 189
54. F.Z. Li, and D.C. Altieri Transcriptional analysis of human survivin gene expression Biochem. J. 344 1999 305 311
55. K. Krysan, F.H. Merchant, L. Zhu, M. Dohadwala, J. Luo, Y. Lin, N. Heuze-Vourc'h, M. Pold, D. Seligson, D. Chia, L. Goodglick, H. Wang, R. Strieter, S. Sharma, and S. Dubinett COX-2-dependent stabilization of survivin in non-small cell lung cancer FASEB J. 2003 03-0369fje
56. C. Denkert, M. Kobel, S. Pest, I. Koch, S. Berger, M. Schwabe, A. Siegert, A. Reles, B. Klosterhalfen, and S. Hauptmann Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma Am. J. Pathol. 160 2002 893 903
57. S.J. Yoo, J.R. Huh, I. Muro, H. Yu, L. Wang, S.L. Wang, R.M. Feldman, R.J. Clem, H.A. Muller, and B.A. Hay Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms Nat. Cell Biol. 4 2002 416 424
58. C.L. Holley, M.R. Olson, D.A. Colon-Ramos, and S. Kornbluth Reaper eliminates IAP proteins through stimulated IAP degradation and generalized translational inhibition Nat. Cell Biol. 4 2002 439 444
59. H.D. Ryoo, A. Bergmann, H. Gonen, A. Ciechanover, and H. Steller Regulation of Drosophila IAP1 degradation and apoptosis by reaper and ubcD1 Nat. Cell Biol. 4 2002 432 438
60. A. Carvalho, M. Carmena, C. Sambade, W.C. Earnshaw, and S.P. Wheatley Survivin is required for stable checkpoint activation in Taxol-treated HeLa cells J. Cell Sci. 116 2003 2987 2998
61. S. Weedon, N. Green, I. McNeish, M. Gilligan, V. Mautner, C. Wrighton, A. Mountain, L. Young, D. Kerr, and P. Searle Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase Int. J. Cancer 86 2000 848 854
62. D.S. Steinwaerder, C.A. Carlson, and A. Lieber DNA replication of first-generation adenovirus vectors in tumor cells Hum. Gene Ther. 11 2000 1933 1948
63. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
64. I.A. McNeish, T. Tenev, S. Bell, M. Marani, G. Vassaux, and N. Lemoine Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells Cancer Gene Ther. 8 2001 308 319
65. T.R. McKay, S. Bell, T. Tenev, V. Stoll, R. Lopes, N.R. Lemoine, and I.A. McNeish Pro-caspase-3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant negative mutant, survivin T34A; a combination gene therapy strategy Oncogene 22 2003 3539 3547
66. T.-C. He, S. Zhou, L. Da Costa, J. Yu, K. Kinzler, and B. Vogelstein A simplified system for generating recombinant adenoviruses Proc. Natl. Acad. Sci. U. S. A. 95 1998 2509 2514
67. P. Pandey, A. Saleh, A. Nakazawa, S. Kumar, S.M. Srinivasula, V. Kumar, R. Weichselbaum, C. Nalin, E.S. Alnemri, D. Kufe, and S. Kharbanda Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90 EMBO J. 19 2000 4310 4322
68. S. Hu, and X. Yang Cellular Inhibitor of Apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO J. Biol. Chem. 278 2003 10055 10060
69. M. MacFarlane, W. Merrison, S.B. Bratton, and G.M. Cohen Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro J. Biol. Chem. 277 2002 36611 36616